Unique Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Sell
1,029
-327
-24% -$334K 0.14% 85
2026
Q1
$1.25M Sell
1,356
-1,173
-46% -$1.19M 0.17% 75
2025
Q4
$2.72M Sell
2,529
-562
-18% -$537K 0.38% 52
2025
Q3
$2.36M Sell
3,091
-191
-6% -$142K 0.35% 61
2025
Q2
$2.56M Buy
3,282
+184
+6% +$143K 0.41% 56
2025
Q1
$2.56M Buy
3,098
+644
+26% +$536K 0.48% 49
2024
Q4
$1.89M Buy
2,454
+1,053
+75% +$872K 0.39% 50
2024
Q3
$1.24M Buy
1,401
+1,054
+304% +$948K 0.28% 57
2024
Q2
$314K Buy
347
+13
+4% +$10.4K 0.08% 74
2024
Q1
$260K Buy
+334
New +$238K 0.07% 80

Other funds holding LLY

Unique Wealth's LLY Position: Q2 2026 in Review

Unique Wealth reduced its Eli Lilly (LLY) stake by 24% in Q2 2026, selling an estimated $334K and leaving 1,029 shares worth $1.23M. The position accounts for 0.14% of the portfolio, ranked #85.

Unique Wealth first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.72M in Q4 2025. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Unique Wealth held 1,029 shares of Eli Lilly worth $1.23M as of Q2 2026.
  • Unique Wealth sold 327 Eli Lilly shares in Q2 2026, an estimated $334K.
  • Eli Lilly made up 0.14% of Unique Wealth's portfolio in Q2 2026, its #85 holding.
  • Unique Wealth first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • Unique Wealth's Eli Lilly position peaked at $2.72M in Q4 2025.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Unique Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.